Duarte Ira
Insider CIK 1488864 · CRTX Principal Accounting Officer · TRSSF Director · HRTX EVP, Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-10-19 | 2026-10-21 | 3,874 | — | $0 | 19,372 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2026-10-19 | 2026-10-21 | 1,102 | $0.36 | $397 | 284,671 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-10-19 | 2026-10-21 | 3,874 | — | — | 285,773 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-31 | 2026-08-03 | 11,694 | — | $0 | 116,944 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2026-07-31 | 2026-08-03 | 3,326 | $0.50 | $1.7K | 281,899 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-31 | 2026-08-03 | 11,694 | — | $0 | 285,225 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-31 | 2026-08-03 | 11,694 | — | $0 | 116,944 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2026-07-31 | 2026-08-03 | 3,326 | $0.50 | $1.7K | 281,899 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-31 | 2026-08-03 | 11,694 | — | — | 285,225 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-30 | 2026-08-03 | 13,535 | — | $0 | 189,492 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-30 | 2026-08-03 | 13,535 | — | $0 | 277,381 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2026-07-30 | 2026-08-03 | 3,850 | $0.50 | $1.9K | 273,531 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-30 | 2026-08-03 | 13,535 | — | $0 | 189,492 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2026-07-30 | 2026-08-03 | 3,850 | $0.50 | $1.9K | 273,531 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-30 | 2026-08-03 | 13,535 | — | — | 277,381 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-19 | 2026-07-20 | 3,874 | — | $0 | 23,246 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2026-07-19 | 2026-07-20 | 1,101 | $0.47 | $517 | 263,846 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-19 | 2026-07-20 | 3,874 | — | $0 | 264,947 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-06-16 | 2026-06-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-06-16 | 2026-06-17 | 12,500 | — | $0 | 264,628 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2026-06-16 | 2026-06-17 | 3,555 | $0.38 | $1.4K | 261,073 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-04-30 | 2026-05-04 | 13,535 | — | $0 | 203,027 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-04-30 | 2026-05-04 | 11,694 | — | $0 | 128,638 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-04-30 | 2026-05-04 | 13,535 | — | $0 | 252,128 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-04-30 | 2026-05-04 | 11,694 | — | $0 | 227,570 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-04-19 | 2026-04-21 | 3,874 | — | $0 | 27,120 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-04-19 | 2026-04-21 | 3,874 | — | $0 | 215,876 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-01-31 | 2026-02-03 | 11,695 | — | $0 | 140,332 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-01-31 | 2026-02-03 | 11,695 | — | $0 | 195,356 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2026-01-30 | 2026-02-03 | 216,561 | — | $0 | 216,561 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2026-01-30 | 2026-02-03 | 216,562 | — | $0 | 216,562 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-01-19 | 2026-01-20 | 3,875 | — | $0 | 30,994 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-01-19 | 2026-01-20 | 3,875 | — | $0 | 183,661 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-10-31 | 2025-11-04 | 11,694 | — | $0 | 152,027 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-10-31 | 2025-11-04 | 11,694 | — | $0 | 179,786 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-10-19 | 2025-10-21 | 3,874 | — | $0 | 34,869 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-10-19 | 2025-10-21 | 3,874 | — | $0 | 168,092 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-07-31 | 2025-08-04 | 11,695 | — | $0 | 163,721 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-07-31 | 2025-08-04 | 11,695 | — | $0 | 164,218 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-07-19 | 2025-07-22 | 3,874 | — | $0 | 38,743 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-07-19 | 2025-07-22 | 3,874 | — | $0 | 152,523 | SEC↗ |
| TSNDF TerrAscend Corp. | A Award | 2025-06-24 | 2025-06-25 | 433,653 | — | $0 | 657,930 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-06-16 | 2025-06-17 | 12,500 | — | $0 | 25,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-06-16 | 2025-06-17 | 12,500 | — | $0 | 148,649 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-04-30 | 2025-05-02 | 11,694 | — | $0 | 175,416 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-04-30 | 2025-05-02 | 11,694 | — | $0 | 136,149 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-04-19 | 2025-04-22 | 3,875 | — | $0 | 42,617 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-04-19 | 2025-04-22 | 3,875 | — | $0 | 124,455 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2025-01-31 | 2025-02-04 | 187,110 | — | $0 | 187,110 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2025-01-31 | 2025-02-04 | 374,220 | — | $0 | 374,220 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-01-19 | 2025-01-22 | 3,874 | — | $0 | 46,492 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-01-19 | 2025-01-22 | 3,874 | — | $0 | 120,580 | SEC↗ |
| TSNDF TerrAscend Corp. | F Tax w/h | 2024-12-31 | 2025-01-03 | 71,704 | $0.65 | $46.6K | 224,277 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2024-10-19 | 2024-10-21 | 3,874 | — | $0 | 50,366 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2024-10-19 | 2024-10-21 | 3,874 | — | $0 | 108,001 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2024-07-19 | 2024-07-22 | 3,875 | — | $0 | 54,240 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2024-07-19 | 2024-07-22 | 3,875 | — | $0 | 104,127 | SEC↗ |
| TSNDF TerrAscend Corp. | A Award | 2024-06-17 | 2024-06-20 | 163,334 | — | $0 | 295,981 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2024-06-16 | 2024-06-17 | 12,500 | — | $0 | 37,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2024-06-16 | 2024-06-17 | 12,500 | — | $0 | 100,252 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2024-04-19 | 2024-04-19 | 3,874 | — | $0 | 58,115 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2024-04-19 | 2024-04-19 | 1,122 | $2.64 | $3.0K | 87,752 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2024-04-19 | 2024-04-19 | 3,874 | — | $0 | 88,874 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2024-01-19 | 2024-01-19 | 61,989 | — | $0 | 61,989 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2024-01-19 | 2024-01-19 | 371,935 | — | $0 | 371,935 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | P Buy | 2023-11-16 | 2023-11-17 | 85,000 | $0.89 | $75.7K | 85,000 | SEC↗ |
| TRSSF TerrAscend Corp. | A Award | 2023-06-22 | 2023-06-26 | 132,647 | — | $0 | 132,647 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer deriv | 2014-02-03 | 2014-02-04 | 7,500 | $3.76 | $28.2K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer deriv | 2014-02-03 | 2014-02-04 | 20,000 | $2.22 | $44.4K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer deriv | 2014-02-03 | 2014-02-04 | 20,000 | $4.25 | $85.0K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer deriv | 2014-02-03 | 2014-02-04 | 8,000 | $4.24 | $33.9K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer | 2014-02-03 | 2014-02-04 | 7,000 | $9.50 | $66.5K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | A Award | 2013-03-07 | 2013-03-11 | 7,000 | — | $0 | 7,000 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | A Award deriv | 2012-02-29 | 2012-04-03 | 7,500 | — | $0 | 7,500 | SEC↗ |